Is PSG.DE stock a buy after this pre-market move?

PSG.DE stock shows a tactical oversold bounce setup; a confirmed move above **€29.50** on sustained volume supports a short-term buy. Long-term buys require monitoring valuation (P/B **9.12**) and inventory metrics. This is not investment advice.

What are the key price targets for PharmaSGP (PSG.DE)?

Near-term target on a validated bounce is **€31.50**; conservative range is **€26.00 — €34.00** based on earnings and peer multiples. Use a stop under **€28.00** to limit downside.

How does Meyka AI rate PSG.DE stock?

Meyka AI rates PSG.DE with a score out of 100: **79.07**, Grade **B+**, Suggestion **BUY**. The grade factors benchmarks, sector, growth, metrics and analyst data; grades are informational, not guarantees.

What model forecast should investors watch for PSG.DE stock?

Meyka AI's forecast model projects **€27.36** in one year, **€29.48** in three years and **€31.56** in five years. Forecasts are projections, not guarantees, and should be used with fundamental checks.

DE Stocks

€29.00 PSG.DE PharmaSGP (XETRA) pre-market 13 Mar 2026: Oversold bounce setup

ByHuzaifa Zahoor March 13, 2026

We see a near-term oversold bounce forming for PSG.DE stock as PharmaSGP Holding SE trades at €29.00 in pre-market XETRA hours on 13 Mar 2026. Volume is elevated at 12,424 versus an average of 5,399, which supports a short-term mean-reversion trade. Fundamentals remain intact: EPS €1.68, P/E 17.26, and a market cap of €333,862,500.00. Investors watching an oversold bounce should weigh the company’s cash, margins and recent sector performance before acting. This write-up gives clear triggers, valuation context and a model-based forecast to frame a measured entry.